The “big guys”, as you call them, are index funds that track the Russell indexes. Nothing should be inferred by this except that their increased holdings make the stock more illiquid, which makes it harder for real biotech funds to buy or sell without moving the stock price dramatically higher or lower.
34.49%institutional . Ownership. Hasn’t changed much. Yes black rock state street and vanguard continue to add but they do with nearly every company, especially since most of the biotech sector has been beaten down. Not too exciting
News 
Market Data 
Discover 
